Analystreport

Stoke Therapeutics, Inc. (NASDAQ: STOK) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating.

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report